Halozyme Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2009 | 97.7% | -427.6% | -426.9% |
| FY2010 | 92.8% | -398.2% | -390.8% |
| FY2011 | 99.5% | -35.4% | -35.2% |
| FY2012 | 97.4% | -126.7% | -126.5% |
| FY2013 | 88.6% | -146.8% | -152.3% |
| FY2014 | 69.8% | -83.7% | -90.8% |
| FY2015 | 78.3% | -20.3% | -23.9% |
| FY2016 | 77.4% | -56.7% | -70.2% |
| FY2017 | 90.2% | 25.6% | 19.9% |
| FY2018 | 93.3% | -45.7% | -52.9% |
| FY2019 | 76.8% | -34.5% | -36.9% |
| FY2020 | 83.8% | 53.9% | 48.2% |
| FY2021 | 81.6% | 62.2% | 90.8% |
| FY2022 | 78.9% | 40.5% | 30.6% |
| FY2023 | 76.8% | 40.7% | 34.0% |
| FY2024 | 84.3% | 54.3% | 43.7% |
| FY2025 | 83.6% | 33.6% | 22.7% |